MBX Biosciences (MBX) Other Working Capital Changes (2023 - 2026)
MBX Biosciences (MBX) reported Other Working Capital Changes of -$41000.0 for Q1 2026, up 2.38% on a YoY basis from -$40046.5 in Q1 2025, and down 127.7% sequentially from $148000.0 in Q4 2025.
MBX Biosciences (MBX) Other Working Capital Changes (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Other Working Capital Changes data on file, last reported at -$41000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 2.38% year-over-year to -$41000.0; the trailing twelve-month figure through Mar 2026 stood at $601000.0 (up 480.38% YoY), and the FY2025 full-year result was $600000.0, up 492.16% from the prior year.
- Other Working Capital Changes fell to -$41000.0 in Q1 2026, from $148000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q3 2025 to a low of -$853000.0 in Q2 2025.
- A 4-year average of $411666.7 and a median of $569000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes retreated 14.29% in 2024 and soared 1471.05% in 2025, its largest moves.
- Tracing MBX's Other Working Capital Changes over 4 years: stood at -$35000.0 in 2023, then declined by 14.29% to -$40000.0 in 2024, then jumped by 470.0% to $148000.0 in 2025, then sank by 127.7% to -$41000.0 in 2026.
- Business Quant data shows MBX's Other Working Capital Changes at -$41000.0 in Q1 2026, $148000.0 in Q4 2025, and -$27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,000.00 |
| Mar 31, 2026 | -41,000.00 |
| Mar 31, 2026 | -41,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | 521,000.00 |
| Jun 30, 2025 | 521,000.00 |
| Jun 30, 2025 | 521,000.00 |
| Mar 31, 2025 | -42,000.00 |
| Mar 31, 2025 | -42,000.00 |
| Mar 31, 2025 | -42,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Sep 30, 2024 | -38,000.00 |